|
EP0678095A1
(en)
|
1993-11-06 |
1995-10-25 |
Taiho Pharmaceutical Co., Ltd. |
Crystalline penicillin derivative, and its production and use
|
|
CA2364342C
(en)
|
1999-04-01 |
2011-02-01 |
Dsm N.V. |
Agglomerates by crystallisation
|
|
ES2258980T3
(es)
|
1999-08-16 |
2006-09-16 |
Revaax Pharmaceuticals Llc |
Composiciones farmaceuticas que comprenden acido clavulanico o derivados del mismo para el tratamiento de trastornos del comportamiento.
|
|
US20030148324A1
(en)
|
2001-02-02 |
2003-08-07 |
Edouard Bingen |
Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides
|
|
FR2812635B1
(fr)
|
2000-08-01 |
2002-10-11 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
|
|
SE0102058D0
(sv)
|
2001-06-08 |
2001-06-08 |
Astrazeneca Ab |
New Salts II
|
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
|
DE10218328A1
(de)
|
2002-03-05 |
2003-09-25 |
Humboldt Uni Zu Berlin Medizin |
Mittel zur präventiven Therapie nach akutem Schlaganfall
|
|
EP1342784A1
(en)
|
2002-03-06 |
2003-09-10 |
Mutabilis S.A. |
ExPEC-specific proteins, genes encoding them and uses thereof
|
|
CA2493870C
(en)
|
2002-03-13 |
2010-07-20 |
Creighton University |
Device and method for detecting antibiotic inactivating enzymes
|
|
FR2842210B1
(fr)
|
2002-07-09 |
2012-12-14 |
Mutabilis |
Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
|
|
US6928313B2
(en)
|
2003-01-27 |
2005-08-09 |
Cardiac Pacemakers, Inc. |
System and method for accessing the coronary sinus to facilitate insertion of pacing leads
|
|
CN1997339A
(zh)
|
2004-02-05 |
2007-07-11 |
通用医疗公司 |
用于治疗皱纹的蛋白酶抑制剂
|
|
EP1580195A1
(en)
|
2004-03-26 |
2005-09-28 |
Mutabilis SA |
Compositions of polypeptides specific to pathogenic ExPEC E. coli strains and their use as vaccines and in immunotherapy
|
|
PT1841432E
(pt)
|
2004-12-02 |
2010-10-25 |
Venus Remedies Ltd |
Composições para combater a resistência aos antibióticos mediada pela beta-lactamase usando inibidores da betalactamase úteis para injecção
|
|
EP1669365A1
(en)
|
2004-12-03 |
2006-06-14 |
Mutabilis SA |
Method for preparing enzymatic substrate analogs as inhibitors of bacterial heptosyl-transferases
|
|
BRPI0517200A
(pt)
|
2004-12-17 |
2008-09-30 |
Venus Remedies Ltd |
combinações de antibióticos, processos de preparação de uma combinação de antibióticos e método de tratamento
|
|
MX2008010350A
(es)
|
2006-02-09 |
2008-10-31 |
Schering Corp |
Formulaciones farmaceuticas.
|
|
CA2641616A1
(en)
|
2006-02-09 |
2007-08-23 |
Schering Corporation |
Pharmaceutical formulations
|
|
EP1845087A1
(en)
|
2006-04-14 |
2007-10-17 |
Mutabilis SA |
Hydroxyphenyl derivatives and biological applications thereof
|
|
EP2029623A2
(en)
|
2006-06-19 |
2009-03-04 |
Mutabilis SA |
Identification of genes implicated in the virulence of streptococcus agalactiae
|
|
US20100022541A1
(en)
|
2006-09-25 |
2010-01-28 |
Sonia Escaich |
Chemical inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
|
|
EP1972629A1
(en)
|
2007-03-23 |
2008-09-24 |
Mutabilis SA |
New imidazolo-heteroaryl derivatives with antibacterial properties
|
|
WO2009008006A2
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
|
WO2009091856A2
(en)
*
|
2008-01-18 |
2009-07-23 |
Merck & Co., Inc. |
Beta-lactamase inhibitors
|
|
EP2141164A1
(en)
|
2008-07-01 |
2010-01-06 |
Mutabilis |
New 1,2,4-triazine derivatives and biological applications thereof
|
|
CN102245605B
(zh)
|
2008-10-14 |
2016-01-27 |
阿斯利康(瑞典)有限公司 |
用于治疗细菌感染的稠合、螺环杂芳族化合物
|
|
US20110020272A1
(en)
|
2009-07-24 |
2011-01-27 |
Ulrich Schubert |
Combination therapy for treating hepatitis viral infection
|
|
AU2010281739B2
(en)
|
2009-10-30 |
2011-06-09 |
Biogenic Innovations, Llc |
Use of methylsulfonylmethane (MSM) to modulate microbial activity
|
|
EP2464346A1
(en)
|
2010-08-30 |
2012-06-20 |
Pulmatrix, Inc. |
Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
|
|
US20140024576A1
(en)
|
2010-12-01 |
2014-01-23 |
Laboratoire Biodim |
Heptose derivatives for use in the treatment of bacterial infections
|
|
PL2657234T3
(pl)
|
2010-12-22 |
2017-06-30 |
Meiji Seika Pharma Co., Ltd. |
Optycznie czynna pochodna diazabicyklooktanowa i sposób jej wytwarzania
|
|
RU2610091C2
(ru)
|
2011-06-17 |
2017-02-07 |
Астразенека Аб |
(2S,5R)-5-[(бензилокси)амино]пиперидин-2-карбоксамид
|
|
NZ616806A
(en)
|
2011-07-26 |
2015-03-27 |
Wockhardt Ltd |
Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
|
|
CA2845108C
(en)
*
|
2011-08-30 |
2015-06-16 |
Wockhardt Limited |
1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
|
|
CA2846107C
(en)
|
2011-09-13 |
2016-06-21 |
Wockhardt Limited |
Nitrogen containing compounds and their use
|
|
US20130108670A1
(en)
|
2011-10-25 |
2013-05-02 |
Biomimetic Therapeutics, Inc. |
Compositions and methods for treating full thickness burn injuries
|
|
WO2013062995A1
(en)
|
2011-10-25 |
2013-05-02 |
Biomimetic Therapeutics, Inc. |
Compositions and methods for treating deep partial and full thickness wounds and injuries
|
|
US8796257B2
(en)
|
2011-12-02 |
2014-08-05 |
Naeja Pharmaceutical Inc. |
Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
|
|
EP2814483A2
(en)
|
2012-02-15 |
2014-12-24 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
US8940897B2
(en)
|
2012-03-30 |
2015-01-27 |
Cubist Pharmaceuticals, Inc. |
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
|
|
WO2013149136A1
(en)
|
2012-03-30 |
2013-10-03 |
Cubist Pharmaceuticals, Inc. |
ISOXAZOLE β-LACTAMASE INHIBITORS
|
|
AR090539A1
(es)
|
2012-04-02 |
2014-11-19 |
Astrazeneca Ab |
COMPUESTOS INHIBIDORES DE b LACTAMASA
|
|
HUE046893T2
(hu)
*
|
2012-05-30 |
2020-04-28 |
Meiji Seika Pharma Co Ltd |
Új ß-laktamáz inhibitor és eljárás elõállítására
|
|
RU2614418C2
(ru)
|
2012-08-25 |
2017-03-28 |
Вокхардт Лимитед |
Производные 1,6-диазабицикло[3.2.1]октан-7-она и их применение для лечения бактериальных инфекций
|
|
US20150306076A1
(en)
|
2012-09-27 |
2015-10-29 |
Cubist Pharmaceuticals, Inc. |
Tazobactam arginine antibiotic compositions
|
|
EP2725029A1
(en)
|
2012-10-29 |
2014-04-30 |
Laboratoire Biodim |
New antibacterial compounds and biological applications thereof
|
|
UA111925C2
(uk)
|
2012-12-11 |
2016-06-24 |
Федора Фармасьютікалз Інк. |
БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
|
|
KR20150089086A
(ko)
|
2013-01-14 |
2015-08-04 |
욱크하르트 리미티드 |
박테리아 감염을 치료하기 위한 조성물 및 방법
|
|
US8889671B2
(en)
|
2013-01-23 |
2014-11-18 |
Astrazeneca Ab |
Compounds and methods for treating bacterial infections
|
|
EP2953626A1
(en)
|
2013-02-06 |
2015-12-16 |
Astrazeneca AB |
Combination therapy for the treatment of nosocomial pneumonia
|
|
WO2014141132A1
(en)
|
2013-03-14 |
2014-09-18 |
Naeja Pharmaceutical Inc. |
NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
|
|
US9364490B2
(en)
|
2013-03-15 |
2016-06-14 |
Laboratoris Sanifit, S.L. |
Use of derivatives containing C—O—P bonds in patients with kidney failure
|
|
ES2495666B1
(es)
|
2013-03-15 |
2015-08-10 |
Laboratoris Sanifit, S.L. |
Uso de derivados con enlaces c-o-p en pacientes con fallo renal
|
|
GB201310542D0
(en)
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
MX2016005160A
(es)
|
2013-10-22 |
2016-10-05 |
Wockhardt Ltd |
Composiciones farmaceuticas que comprenden agentes antibacterianos.
|
|
CA2934492A1
(en)
|
2014-01-21 |
2015-07-30 |
Wockhardt Limited |
Nitrogen containing compounds and their use
|
|
KR20160115946A
(ko)
|
2014-02-03 |
2016-10-06 |
욱크하르트 리미티드 |
(2s,5r)-1,6-다이아자-바이사이클로[3.2.1]옥테인-2-카보나이트릴-7-옥소-6-(설포옥시)-모노 소듐 염의 제조 공정
|
|
KR20160115941A
(ko)
|
2014-02-20 |
2016-10-06 |
욱크하르트 리미티드 |
항세균제를 포함하는 제약학적 조합
|
|
EP2913330A1
(en)
|
2014-02-27 |
2015-09-02 |
Laboratoire Biodim |
Condensed derivatives of imidazole useful as pharmaceuticals
|
|
JP2017507162A
(ja)
|
2014-03-14 |
2017-03-16 |
ウォックハート リミテッド |
抗菌薬を含む医薬組成物
|
|
AP2016009374A0
(en)
|
2014-03-24 |
2016-08-31 |
Novartis Ag |
Monobactam organic compounds for the treatment of bacterial infections
|
|
CN107980000A
(zh)
|
2014-04-18 |
2018-05-01 |
沃克哈特有限公司 |
包含抗菌剂的药物组合物
|
|
MX2016013428A
(es)
|
2014-04-18 |
2017-04-13 |
Wockhardt Ltd |
Composiciones farmaceuticas que comprenden agentes antibacterianos.
|
|
SG10201906842WA
(en)
|
2014-05-29 |
2019-08-27 |
Entasis Therapeutics Ltd |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
US20150361108A1
(en)
|
2014-06-11 |
2015-12-17 |
VenatoRx Pharmaceuticals, Inc. |
Orally bioavailable beta-lactamase inhibitors
|
|
JP6764862B2
(ja)
|
2014-11-17 |
2020-10-07 |
エンタシス・セラピューティックス・リミテッド |
耐性細菌感染症の治療のための併用療法
|
|
GB2533136A
(en)
|
2014-12-11 |
2016-06-15 |
Antabio Sas |
Compounds
|
|
WO2016116788A1
(en)
|
2015-01-24 |
2016-07-28 |
Wockhardt Limited |
Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
|
|
WO2016128867A1
(en)
|
2015-02-12 |
2016-08-18 |
Wockhardt Limited |
Azetidinone containing compounds and their use in treatment of bacterial infections
|
|
US10570131B2
(en)
|
2015-03-31 |
2020-02-25 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
US10072006B2
(en)
|
2015-03-31 |
2018-09-11 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
WO2016156597A1
(en)
|
2015-04-03 |
2016-10-06 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
KR102713561B1
(ko)
|
2015-05-07 |
2024-10-08 |
무타빌리스 |
헤테로사이클릭 화합물 및 세균성 감염을 예방 또는 치료하는 이의 용도
|
|
WO2017002089A1
(en)
|
2015-07-02 |
2017-01-05 |
Wockhardt Limited |
Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
|
|
WO2017002083A1
(en)
|
2015-07-02 |
2017-01-05 |
Wockhardt Limited |
Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
|
|
WO2017002087A1
(en)
|
2015-07-02 |
2017-01-05 |
Wockhardtlimited |
Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
|
|
WO2017002086A1
(en)
|
2015-07-02 |
2017-01-05 |
Wockhardt Limited |
Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
|
|
CN106467705B
(zh)
|
2015-08-17 |
2019-02-22 |
3M创新有限公司 |
防滑液、防滑件及其制备方法
|
|
WO2017037607A1
(en)
|
2015-09-01 |
2017-03-09 |
Wockhardt Limited |
(aminomethylidene)amino-substituted (2s,5r)-6-(sulfonyl)-7-oxo-1,6-diazabicyclo[3.2.1 ]octane-2-carboxamide derivatives with antibacterial activity
|
|
WO2017096472A1
(en)
|
2015-12-10 |
2017-06-15 |
Naeja-Rgm Pharmaceuticals Inc. |
Cephem compounds, their production and use
|
|
EP3184529A1
(en)
|
2015-12-23 |
2017-06-28 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
EP3426391A4
(en)
|
2016-03-11 |
2019-08-28 |
California Institute of Technology |
COMPOSITIONS AND METHODS FOR ACYLATING LACTAMEN
|
|
WO2017203266A1
(en)
|
2016-05-25 |
2017-11-30 |
Entasis Therapeutics Limited |
Combination therapy for treatment of resistant bacterial infections
|
|
EP3471724A1
(en)
|
2016-06-17 |
2019-04-24 |
Wockhardt Limited |
Antibacterial compositions
|
|
DK3512851T3
(en)
|
2016-09-16 |
2022-10-17 |
Entasis Therapeutics Ltd |
Beta-lactamase inhibitor compounds
|
|
EP3300736B1
(en)
|
2016-09-30 |
2021-05-05 |
Mutabilis |
Composition comprising antibiotic compound and an heterocyclic compound and their use in preventing or treating bacterial infections
|
|
WO2018129008A1
(en)
|
2017-01-04 |
2018-07-12 |
Entasis Therapeutics Inc. |
Compounds and methods for treating bacterial infections
|
|
CN110392684A
(zh)
|
2017-02-06 |
2019-10-29 |
拜欧蒂姆公司 |
新型杂环化合物及其在预防或治疗细菌感染中的用途
|
|
EP3357924A1
(en)
|
2017-02-06 |
2018-08-08 |
Mutabilis |
Novel heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
WO2018208769A1
(en)
|
2017-05-08 |
2018-11-15 |
Entasis Therapeutics, Inc. |
Compounds and methods for treating bacterial infections
|
|
CN115745910B
(zh)
|
2017-07-21 |
2025-05-27 |
安塔比奥公司 |
化学化合物
|
|
CN107501265B
(zh)
|
2017-10-09 |
2019-05-28 |
台州职业技术学院 |
一种7-氧代-二氮杂二环[3,2,1]辛烷衍生化合物及其制备方法和应用
|
|
WO2019093450A1
(ja)
|
2017-11-10 |
2019-05-16 |
塩野義製薬株式会社 |
ジアザビシクロオクタン誘導体
|
|
EP3572411A1
(en)
|
2018-05-21 |
2019-11-27 |
Antabio SAS |
Thiazole derivatives as metallo-beta-lactamase inhibitors
|
|
EP3604315A1
(en)
|
2018-07-30 |
2020-02-05 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
EP3604309A1
(en)
|
2018-07-30 |
2020-02-05 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
US11905286B2
(en)
*
|
2018-08-09 |
2024-02-20 |
Antabio Sas |
Diazabicyclooctanones as inhibitors of serine beta-lactamases
|